Chronic Disease Management Market Size, Share & Industry Analysis, By Type (Software and Services), By Disease Indication (Cardiovascular Diseases, Diabetes, Chronic Respiratory Diseases, Cancer, and Others), By Deployment Type (Cloud-based, On-Premise, and Hybrid), By Service Provider (Hospitals & Health Systems, Physician Practices & Specialty Clinics, Home Healthcare & Community-Based Care Providers, and Others), and Regional Forecast, 2026-2034

The chronic disease management market size was valued at USD 10.13 billion in 2025. The market is projected to grow from USD 11.28 billion in 2026 to USD 28.60 billion by 2034, exhibiting a CAGR of 12.3% during the forecast period.

Chronic disease management refers to the comprehensive care approach used to treat and manage long-term health conditions that require continuous attention. The growing prevalence of chronic diseases, increasing demand for chronic disease management services, advancements in these products and services, and increasing healthcare expenditure are resulting in an increasing adoption of these services in the market. The growing aging population is further augmenting the adoption of chronic disease management in the market.

• For instance, according to the 2025 statistics published by the International Diabetes Federation (IDF), about 6.5 million adults are affected by diabetes in Germany.

Furthermore, the increasing emphasis on the provision of novel services among the key companies, including Teladoc Health, Inc., and Hinge Health, Inc. is further contributing to the demand for these services in the market.

Chronic Disease Management Market Trends

Increasing Shift toward Artificial Intelligence and Predictive Analytics is an Emerging Market Trend

The incorporation of artificial intelligence (AI) and predictive analytics is enabling providers to shift from reactive disease management toward proactive, risk-based and personalized care. Machine-learning algorithms analyze laboratory results, longitudinal information from Electronic Health Record (EHR), medications, connected devices, patient-reported outcomes, and behavioral data to detect patients at elevated risk of disease progression, complications, or hospitalization, and further provide improved patient outcomes. This enables physicians and care-management professionals to prioritize high-risk patients and initiate interventions before significant clinical deterioration occurs. It also results in improved health outcomes, thereby contributing to growing adoption and demand for these services globally.

• For instance, according to 2024 data published by the Office of National Coordinator for Health Information Technology, about 71% of hospitals reported using predictive AI integrated with EHR.

Market Dynamics

Market Drivers

Download Free sample to learn more about this report.

Increasing Prevalence of Chronic Conditions to Drive Market Growth

The increasing prevalence of chronic conditions and an aging population, is anticipated to increase patient admissions in healthcare settings, including hospitals and other clinical facilities, thus resulting in chronic disease management market growth.

• For instance, according to 2023 data published by the Government of China, approximately 297 million people were aged 60 and above in China.

Additionally, growing healthcare expenditure, increasing demand for wearable devices, development of infrastructure, and others is further driving market expansion. Growing focus of key companies on the provision of innovative services is also anticipated to boost market development.

Market Restraints

Limited Number of Healthcare Specialists to Restrict Market Growth

The inadequate number of qualified healthcare professionals is expected to hamper the market growth. Healthcare facilities require qualified healthcare professionals to ensure the provision of chronic disease management services among the patient population. However, the limited availability of qualified healthcare professionals is restricting these facilities’ ability to expand their service capacity despite the growing demand for chronic disease management services, thereby hampering market growth.

• For instance, according to the 2026 data published by the Independent Online (IOL), there are only 157,097 registered nurses in South Africa.

Market Opportunities

Expansion of Healthcare Infrastructure to Create Key Opportunities

The expansion of healthcare infrastructure in emerging nations presents a major growth opportunity for the global market. There is a growing focus on healthcare investment, qualified specialists, increasing digitalization, and expansion of reimbursement frameworks in countries, including South Africa, India, Brazil, and others. Increasing advancement in healthcare infrastructure, along with growing healthcare spending, is contributing to increasing demand for these services in the market.

• According to 2024 data published by the International Trade Administration (ITA), healthcare spending is USD 135.0 billion in Brazil.

Market Challenges

Limited Healthcare Access in Emerging Nations to Hinder Market Growth

There is a growing demand for novel chronic disease management among the patient population. However, limited access to healthcare facilities in developing nations remains a key challenge for the global market. The limited number of developed hospitals and other healthcare facilities, trained healthcare professionals, and an insufficient reimbursement framework are resulting in delayed patient visits, especially during respiratory distress, and cardiac emergencies, thereby limiting the adoption of these services in the market.

• For instance, according to the data published by International Citizens Insurance (ICI), it was reported that there are only 600 hospitals in South Africa.

SEGMENTATION ANALYSIS

By Type

Increasing Prevalence of Chronic Conditions Led to Services Segment’s Dominance

Based on the type, the market is classified into software and services.

To know how our report can help streamline your business, Speak to Analyst

The services segment held the largest chronic disease management market share in 2025. Growing chronic disease burden is resulting in an increasing demand for chronic disease management services, including care-plan maintenance and recurring monitoring, among others in healthcare facilities. Additionally, increasing awareness about the benefit of these services, government initiatives and growing number of key companies providing novel services, are also some of the factors anticipated to contribute to the segment growth.

• For instance, according to 2026 statistics published by the Centers for Disease Control & Prevention (CDC), approximately 1.7 million adults and more than 18,000 children in the U.S. develop sepsis annually.

The software segment is expected to grow at a CAGR of 13.3% over the forecast period.

By Disease Indication

Growing Disease Burden for Cardiovascular Disorders Led to Dominance of Segment

Based on disease indication, the market is segmented into cardiovascular diseases, diabetes, chronic respiratory diseases, cancer, and others.

The cardiovascular diseases segment dominated the global market in 2025 and held a share of 29.5% in 2025. This growth is due to surging number of chronic conditions, including cardiovascular diseases, among the adult population. This, along with growing technological advancements in the products and software, among others are some of the other factors contributing to the overall segmental growth.

• For instance, according to 2024 data published by the Centers for Disease Control & Prevention (CDC), about 1 in 20 adults were affected by coronary artery disease in the U.S.

The cancer segment is set to flourish with a growth rate of 13.9% during the forecast period.

By Deployment Type

Increasing Adoption of Application Programming Interfaces (APIs) Led to Dominance of Cloud-based Segment

Based on deployment type, the market is segmented into cloud-based, on-premise, and hybrid.

The cloud-based segment dominated the global market in 2025 with a share of 57.5%. The growth is due to the increasing demand for chronic disease management software. This, along with growing number of key companies focusing on developing innovative cloud-based software is further contributing to the segmental growth.

• For instance, according to the 2023 data published by the Office of the National Coordinator for Health Information Technology (ONCHIT), nine in ten hospitals used application programming interfaces to enable apps to grant patient access to EHR data.

The on-premise segment is set to expand at a growth rate of 4.8% during the forecast period.

By Service Provider

Increasing Number of Hospitals & Health Systems Led to Segmental Dominance

Based on service provider, the market is divided into hospitals & health systems, physician practices & specialty clinics, home healthcare & community-based care providers, and others.

The hospitals & health systems segment dominated the market in 2025. The increasing number of hospitals, high volume of comorbid patients, and increasing adoption of EHRs are some of the crucial factors contributing to the segment’s growth. This, along with growing adoption of technologically advanced devices and benefits including multi-specialty care, 24/7 medical technology, and others is expected to contribute to the segmental growth. Furthermore, the segment is set to hold a 39.4% share in 2026.

In addition, physician practices & specialty clinics segment is projected to grow at a CAGR of 11.2% during the forecast period.

Chronic Disease Management Market Regional Outlook

Based on region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

The North America market held a dominant share in 2024, valued at USD 4.26 billion, and also took the leading share in 2025 with USD 4.67 billion revenue. The increasing burden of chronic conditions and increasing product approvals among the key companies are some of the crucial factors contributing to regional market growth.

• For instance, in August 2023, Welldoc, Inc., a digital health company revolutionizing chronic care, received FDA 510(k) approval for its diabetes digital health solution, BlueStar.

U.S. Chronic Disease Management Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 4.67 billion in 2026, accounting for roughly 41.4% of global sales.

Europe

Europe is projected to record a growth rate of 10.7% over the forecast period, which is the second highest among all regions, and reach a valuation of USD 2.54 billion by 2026. The increasing prevalence of chronic conditions among patients is expected to contribute to the market growth.

U.K. Chronic Disease Management Market

The U.K. market in 2026 is estimated at around USD 0.48 billion, representing roughly 4.3% of global revenues.

Germany Chronic Disease Management Market

Germany’s market is projected to reach approximately USD 0.53 billion in 2026, equivalent to around 4.7% of global sales.

Asia Pacific

Asia Pacific is estimated to reach USD 2.47 billion in 2026 and secure the position of the third-largest region in the market. The benefits offered by these chronic disease management services, including enhanced patient outcomes, improved medication adherence, and increasing healthcare access, are likely to support the market growth.

Japan Chronic Disease Management Market

The Japan market in 2026 is estimated at around USD 0.61 billion, accounting for roughly 5.4% of global revenues. Japan has historically reported a relatively increasing focus on population health management programs, with a large demand for digital health solutions.

China Chronic Disease Management Market

China’s market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 0.63 billion, representing roughly 5.6% of global sales.

India Chronic Disease Management Market

The Indian market in 2026 is estimated at around USD 0.28 billion, accounting for roughly 2.5% of global revenues.

Latin America and Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market during the forecast period. The Latin America market is set to reach a valuation of USD 0.64 billion in 2026.  The growth is due to the increasing demand for wearable devices, AI powered products, among others, in the region. The Middle East & Africa are also expected to grow at a considerable rate due to the growing demand for early detection and the introduction of novel disease management programs among the key companies in the market. In the Middle East & Africa, the GCC is set to reach a value of USD 0.19 billion in 2026.

South Africa Chronic Disease Management Market

The South Africa market is projected to reach around USD 0.10 billion in 2026, representing roughly 0.9% of global revenues.

Competitive Landscape

Key Industry Players

Increasing Launches of New Programs to Support Market Competition

A robust and diversified product and services portfolio, along with strong emphasis on strategic initiatives globally, is one of the major factors contributing to the dominance of these companies in the market. Teladoc Health, Inc., and Hinge Health, Inc., were major companies in the market in 2025. Furthermore, the growing focus of key companies on launching innovative programs to cater to the growing demand for chronic disease management is likely to strengthen their presence,.

• For instance, in April 2025, Teladoc Health, Inc., the global company in virtual care, introduced its next-generation Cardiometabolic Health Program to enhance population health and prevent the progression of diabetes, hypertension, and obesity.

Other key players, including Welldoc, Inc., and others, are also growing in the market, primarily due to their increasing emphasis on launching advanced software to strengthen their presence in the market.

List of Key Chronic Disease Management Companies

• Teladoc Health, Inc. (U.S.)
• Hinge Health, Inc. (U.S.)
• Omada Health Inc. (U.S.)
• Sword Health, Inc. (U.S.)
• Vida Health, Inc. (U.S.)
• Welldoc, Inc. (U.S.)
• Hello Heart (U.S.)
• Lark Technologies, Inc. (U.S.)
• HealthSnap, Inc. (U.S.)
• ChartSpan (U.S.)

KEY INDUSTRY DEVELOPMENTS

• April 2026: Sidekick Health, a digital health innovation company, launched its musculoskeletal (MSK) health program and pain management support. These clinician-backed resources are available alongside 24+ conditions spanning cardiometabolic, oncology, behavioral health, women's health, inflammation and immunology, discharge management, and medication support — all within a single platform.
• January 2026: MOBE, LLC partnered with Sidekick Health, a digital platform for multi-condition and medication support. This partnership expanded the company’s whole-person model and enhanced its delivery of personalized, clinically supported condition management for populations with multiple chronic conditions (MCC).
• May 2025: ChartSpan, a preventative care service provider, partnered with the Colorado Hospital Association (CHA) to offer comprehensive care management programs to Medicare beneficiaries throughout Colorado.
• October 2024: CopilotIQ, the health tech company helping older Americans with chronic conditions live longer and healthier lives, merged with Biofourmis, a global technology-enabled care delivery company, delivering in-home care solutions serving enterprise healthcare customers. This helped the companies to increase their brand presence.
• June 2024: HealthSnap, a virtual care management platform, partnered with Mount Sinai Medical Center, the private, independent not-for-profit teaching hospital in Florida, to improve remote patient monitoring (RPM) and chronic care management (CCM) among the patient population.

REPORT COVERAGE

The report provides a detailed chronic disease management market analysis and focuses on key aspects such as leading companies and market segmentation, including type, disease indication, deployment type, and service provider. Besides this, the global report offers insights into the market growth trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market over recent years.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation

Research Methodology

1. Bottom-Up Approaches

Approach 1: Revenues and Market Share of Major Chronic Disease Management Players

• Collect chronic-disease-management-specific revenue from annual reports, SEC filings, investor presentations, earnings releases, company websites, and management disclosures.
• Map the 15 profiled companies and other relevant providers to in-scope software and service revenue, separating general telehealth, acute care, standalone device, wellness and unrelated digital-health revenue.
• Use reported revenue directly where a company is sufficiently pure-play; where diversified, apply a transparent CDM attribution factor; where private revenue is unavailable, use conservative scale-based low/base/high proxies and clearly label them as analyst estimates.
• Assess enrolled/managed patients, members, covered lives, enterprise customers, provider partnerships, disease breadth and geographic presence as scale cross-checks.
• Prevent double counting where software is bundled into managed-service contracts or where acquired companies are consolidated into a current parent/operator.
• Triangulate the company cohort with an estimated long-tail share to derive an implied global market value.

Approach 2: Epidemiology, Eligible-Patient, Utilization and Revenue-per-Patient Model

• Estimate diagnosed/treated populations for cardiovascular diseases, diabetes, chronic respiratory diseases, cancer, and other qualifying chronic conditions by country.
• Convert total chronic-disease populations into an addressable population for structured longitudinal management, recognizing that not every diagnosed patient is enrolled in a commercial CDM program.
• Apply country-specific program penetration using digital-health maturity, reimbursement, provider capacity, covered-life access and observed enrollment indicators.
• Estimate utilization and annual revenue per enrolled/managed patient using PMPM care-management fees, software subscriptions, program fees and implementation/service economics.
• Adjust for patients with multiple chronic conditions so that the same person is not counted repeatedly across disease-indication buckets.
• Aggregate country-level patient economics into regional and global market values and compare implied penetration with credible provider and national-program benchmarks.

Approach 3: Provider Installed-Base, Service Capacity and Utilization Model

• Estimate the addressable provider base across hospitals & health systems, physician practices & specialty clinics, home/community providers and other qualifying CDM providers.
• Apply country- and provider-type-specific adoption rates for structured chronic-care software or managed services.
• Estimate average enrolled/managed patients per active provider and normalize for large integrated systems versus small independent practices.
• Apply annual software/service revenue per active patient/provider, with separate consideration of implementation and ongoing managed-service economics.
• Cross-check provider-derived revenues against national reimbursement structures and company-reported customer/provider scale.
• Reconcile provider capacity to patient-based demand so that modeled enrollment does not exceed plausible service delivery capacity.

2. Top Down Approaches

Approach 1: Analysis of Parent Addressable Chronic-Care Market

• Analysis of country-level healthcare expenditure associated with chronic diseases, primary care, digital health, remote care, and longitudinal chronic-care management to establish the broader addressable spending pool.
• Estimation of the proportion of chronic-disease healthcare spending attributable specifically to structured chronic disease management software and services, based on reimbursement availability, provider adoption, CDM program enrollment, digital-health penetration, and care-management utilization.
• Application of country-specific adjustment factors for software penetration, remote patient monitoring adoption, cloud/digital infrastructure, physician and hospital participation, payer coverage, and revenue-per-managed-patient levels.
• Exclusion of expenditure attributable to pharmaceuticals, standalone medical devices, diagnostic services, acute treatment, routine hospital/physician care, payer claims administration, revenue-cycle management, and generic healthcare IT/telehealth outside the defined CDM scope.
• Assessment of the share of chronic-care expenditure represented by software subscriptions, managed chronic-care programs, care coordination, remote monitoring management, coaching, adherence support, and related implementation/services.
• Adjustment for differences between mature and emerging markets based on chronic-disease burden, reimbursement maturity, digital-health adoption, healthcare access, provider capacity, and affordability.
• Aggregation of country-level addressable CDM spending into regional and global market estimates, followed by comparison with company-revenue, patient-enrollment, utilization, and revenue-per-patient models to finalize the market size.

3. List of Key Sources

• Annual reports, SEC filings, investor presentations, earnings transcripts, financial statements, and chronic-disease-management-specific revenue disclosures of major market participants.
• Company websites, software/service portfolios, customer-enrollment disclosures, covered lives, partnerships, product launches, acquisitions, and geographic-expansion announcements.
• CMS and CDC – chronic care management, RPM/APCM reimbursement, utilization, chronic-disease prevalence, and U.S. disease-burden data.
• WHO, OECD, World Bank, and Eurostat – chronic disease burden, healthcare expenditure, demographics, healthcare utilization, and cross-country health-system indicators.
• NHS England and U.K. Department of Health and Social Care – long-term-condition management, primary-care programs, QOF, digital-health initiatives, and chronic-care utilization.
• MHLW/PMDA Japan, NHC/NHSA/NMPA China, MoHFW/CDSCO India, and Australian Department of Health/AIHW/TGA – chronic-care programs, reimbursement, digital-health policies, utilization, and regulatory requirements.
• Disease-specific organizations including ADA, IDF, AHA, ESC, GOLD, GINA, and relevant national associations for disease prevalence, treatment pathways, and clinical guidance.
• National disease registries, public-health surveillance databases, and epidemiological studies covering cardiovascular disease, diabetes, respiratory disease, cancer, and other chronic conditions.
• Peer-reviewed publications from PubMed, JAMA, The Lancet, BMJ, Nature, BMC, and other academic journals for CDM effectiveness, remote monitoring, AI, patient adherence, and health-economic evidence.
• National reimbursement databases, payer policies, health technology assessment agencies, and government healthcare programs for CCM, RPM, virtual care, and value-based reimbursement.
• Healthcare-provider and health-system reports covering chronic-care programs, population health, virtual care, clinical outcomes, and technology partnerships.
• Regulatory and digital-health authorities including FDA, European Commission, PMDA, NMPA, CDSCO, and TGA for SaMD, AI-enabled software, cybersecurity, validation, registration, and post-market requirements.
• Published healthcare-industry articles and specialist blogs may be used as secondary validation where they clearly reference government, company, or peer-reviewed primary data.
• Chronic-care enrollment, managed-patient populations, covered lives, PMPM pricing, revenue per patient, provider adoption, reimbursement levels, and digital-health penetration used as market-sizing inputs.
• M&A transactions, partnerships, technology integrations, program launches, reimbursement changes, and geographic expansions used for competitive and forecast validation.
• Third-party syndicated market-research publishers should not be used as primary evidence for market sizing.

4. Primary Interviews

Supply Side Interviews: 60%

• Key Respondents:
• Executives at chronic disease management software and managed-care providers
• Product, clinical operations, digital-health and AI leaders
• Business development, partnerships, payer contracting and enterprise sales executives
• Health-system care-management and virtual-care program leaders
• Pharmacist-led and home/community chronic-care program operators
• Implementation, interoperability, cybersecurity and healthcare IT integration specialists
• Demand Side Interviews: 40%
• Key respondents:
• Primary-care physicians and practice administrators
• Cardiologists, endocrinologists, pulmonologists, oncologists and other chronic-disease specialists
• Hospital and health-system population-health / care-management leaders
• Home-health and community-care administrators
• Health-plan clinical program and value-based-care leaders
• Employer-benefit and digital-health procurement decision makers
• Patient-engagement, nursing and care-coordination leaderso